NICE has said it expects to evaluate dozens of potential treatments for Alzheimer’s disease over the next few years. Elisabeth Mahase examines what we know about these drugs This year the National ...

Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...

New research from Scripps Research links Alzheimer’s disease and alcohol use disorder, showing similar gene expression ...

A groundbreaking study from the University of California has hinted that following a keto diet might just be the secret to ...

Arkansas Attorney General Tim Griffin announced the arrest of three people on Thursday for cases of Medicaid fraud and elder ...

Longer-term, Eisai and Biogen are hoping for further evidence to support Leqembi from the phase 3 AHEAD 3-45 trial, which ...

Six years after his Alzheimer’s diagnosis, 90-year-old Zelik Bocknek (Zel) refuses to slow down — and he believes his active ...

Deep sleep could be key to forestalling slow declines in brain health that may one day lead to Alzheimer's disease, the most ...

Neurologist Dona Murphey, the founder of website PrognosUs, hopes her platform can give caregivers a place to find support in ...

Cassava Sciences' stock is highly shorted, with potential reward tied to the upcoming Phase 3 trial results for simufilam.

John Reichart says he's been assembling Christmas decor in his garage since September. On Thursday, the final lawn ornament ...

Three common vaccines could potentially lower your risk of developing Alzheimer's disease and promote better brain health.